Status:
COMPLETED
Delayed Antibiotic Therapy in Non-severe Ventilator Acquired Pneumonia (VAP)
Lead Sponsor:
Nantes University Hospital
Conditions:
Ventilator Associated Pneumonia
Critical Care
Eligibility:
All Genders
18+ years
Brief Summary
This retro-prospective monocentric observational study compare the impact of the implementation of a restrictive (delayed) versus aggressive (immediate) antibiotic strategy for Ventilator Acquired Pne...
Detailed Description
Ventilator acquired pneumonia (VAP) is the leading cause of nosocomial infection in intensive care patients, and has been associated with increased antibiotic consumption, increased morbidity and mort...
Eligibility Criteria
Inclusion
- Under mechanical ventilation from more than 48 hours
- Suspected for a ventilator acquired pneumonia, requiring a distal pulmonary bacterial sample
Exclusion
- New or worsening shock requiring vasopressor
- New or worsening severe hypoxemia (PaO2/FiO2\<150 in FiO2≥60% and peep 10)
- Patient under veno-veinous extracorporeal membrane oxygenation
- Neutropenia \<1G/L or immunosuppressive treatment (including corticosteroids \>6 months or \>0.5mg/kg/j)
- Disease (endocarditis, spondylodyscitis, deep abcedation…) requiring prolonged antibiotic therapy
Key Trial Info
Start Date :
January 6 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 28 2023
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT05205525
Start Date
January 6 2022
End Date
January 28 2023
Last Update
March 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Nantes Hospital
Nantes, France, 44000